🔎 Trials Near Me

Início › Leucemia Mieloide Aguda › New Jersey › Edison

Ensaios clínicos de Leucemia Mieloide Aguda em Edison, NJ

20 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Edison e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RecrutandoFase 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades de 18 a 59 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecrutandoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

RecrutandoFase 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades de 18 a 59 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecrutandoFase 3
  • Saint Peter's University Hospital, New Brunswick · a 3 mi de distância
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · a 3 mi de distância
6 Months – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RecrutandoFase 1/2
  • Saint Peter's University Hospital, New Brunswick · a 3 mi de distância
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · a 3 mi de distância
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecrutandoFase 3
  • Rutgers Biomedical and Health Sciences, New Brunswick · a 3 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07007312

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

RecrutandoFase 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 60 e acima · Todos os sexos · Atualizado em 17 de jul. de 2026 · NCT07392242

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecrutandoEstudo observacional
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

RecrutandoFase 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

RecrutandoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 1 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

RecrutandoFase 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 12 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

RecrutandoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
Idades de 18 a 70 · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecrutandoFase 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
Idades 12 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecrutandoFase 1
  • Rutgers Cancer Institute, New Brunswick · a 3 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

RecrutandoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

RecrutandoFase 2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 24 de fev. de 2026 · NCT06773208

Ensaios de Leucemia Mieloide Aguda em outras cidades

Outros estudos em Edison

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.